Search Results - "Landsburg, D. J."
-
1
Bendamustine is Safe and Effective for Lymphodepletion Before Tisagenlecleucel in Patients with Refractory or Relapsed Large B-Cell Lymphomas
Published in Annals of oncology (01-09-2022)“…Anti-CD19 chimeric antigen receptor T-cell immunotherapy (CAR-T) is now a standard treatment for relapsed or refractory B-cell non-Hodgkin lymphomas; however,…”
Get full text
Journal Article -
2
-
3
-
4
Outcomes with bendamustine lymphodepletion and brexucabtagene autoleucel for mantle cell lymphoma
Published in Hematological oncology (01-06-2023)Get full text
Journal Article -
5
-
6
-
7
TIME‐TO‐RESPONSE FOR PATIENTS WITH RELAPSED/REFRACTORY AGGRESSIVE B CELL NON‐HODGKIN LYMPHOMA TREATED WITH POLATUZUMAB‐BASED THERAPY
Published in Hematological oncology (01-06-2021)Get full text
Journal Article -
8
-
9
Intraventricular Brain Injection of Adeno-Associated Virus Type 1 (AAV1) in Neonatal Mice Results in Complementary Patterns of Neuronal Transduction to AAV2 and Total Long-Term Correction of Storage Lesions in the Brains of β-Glucuronidase-Deficient Mice
Published in Journal of Virology (01-06-2003)“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
10
Structure-Based Mutagenesis of Herpes Simplex Virus Glycoprotein D Defines Three Critical Regions at the gD-HveA/HVEM Binding Interface
Published in Journal of Virology (01-07-2003)“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
11
Structure-Based Analysis of the Herpes Simplex Virus Glycoprotein D Binding Site Present on Herpesvirus Entry Mediator HveA (HVEM)
Published in Journal of Virology (01-11-2002)“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
12
Contribution of cysteine residues to the structure and function of herpes simplex virus gH/gL
Published in Virology (New York, N.Y.) (20-02-2005)“…In HSV types 1 and 2, gH forms a noncovalent heterodimer with gL. Previous studies demonstrated that the first 323 amino acids of gH1 and the first 161 amino…”
Get full text
Journal Article -
13
Radiation Therapy (RT)-Based Salvage Therapy for Classical Hodgkin Lymphoma (cHL)
Published in International journal of radiation oncology, biology, physics (01-11-2021)“…Most patients (pts) with relapsed/refractory (RR) cHL undergo salvage chemotherapy (CT) followed by curative-intent autologous stem cell transplant (ASCT). For…”
Get full text
Journal Article -
14
17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023
Published in Hematological oncology (01-06-2023)Get full text
Journal Article -
15
17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023
Published in Hematological oncology (01-06-2023)Get full text
Journal Article -
16
-
17
REAL WORLD OUTCOMES OF OBINUTUZUMAB MONOTHERAPY IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
Published in Hematological oncology (01-06-2019)Get full text
Journal Article -
18
CD19‐DIRECTED CAR T CELL THERAPY (CTL019) FOR RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL AND FOLLICULAR LYMPHOMAS: FOUR YEAR OUTCOMES
Published in Hematological oncology (01-06-2019)Get full text
Journal Article -
19
SURVIVAL FOLLOWING FIRST RELAPSE IN YOUNGER PATIENTS WITH MANTLE CELL LYMPHOMA
Published in Hematological oncology (01-06-2021)Get full text
Journal Article -
20